Skip to main content
13 November 2026
16 September 2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. Jazz completed the acquisition of Actio Biosciences through the merger of Knight Acquisition Corp. (the "Merger Sub"), a D…

15 September 2026

Jaguar Acquires Laminar LAA Program from Johnson & Johnson

Jaguar LAA, Inc, a privately held medical device company announced the acquisition of assets related to the Laminar program, focused on addressing the left atrial appendage in patients with non-valvular atrial fibrillation ("AFib"), from Johnson & Johnson. The transaction brings key Laminar program assets togethe…

10 September 2026

Novo Holdings Expands Footprint in China’s Medtech Sector

 Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd., a China-based contract development and manufacturing organisation (CDMO) specialising in advanced wound care products. GL Capital, one of China's leading health…

09 September 2026

Labcorp Acquires MLM Medical Labs to Expand Global Clinical Trial Capabilities

Labcorp a global leader of innovative and comprehensive laboratory services, announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed. The ac…

07 September 2026

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical

Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited announced that it has entered into a strategic partnership with Qilu Pharmaceutical Co., Ltd. (hereinafter referred to as Qilu), for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda® (pembrolizumab), for the United States As…

02 September 2026

Medtronic Invests $700M in Cornerstone Robotics

Medtronic, a global leader in healthcare technology, announced a strategic partnership with Cornerstone Robotics, an innovative surgical robotics company committed to advancing minimally invasive surgery and improving access to the latest surgical care worldwide. The approximately $700 million investment includes righ…

31 August 2026

Monash Health, Data4Life Strengthen Clinical Research Collaboration

Monash Health, the largest public health service in Victoria, Australia, has signed a Memorandum of Understanding (MoU) with Data4Life, an international nonprofit digital health organization funded by the Hasso Plattner Foundation. The announcement was made by Associate Professor Tam C. Nguyen, Director of Research &a…

31 August 2026

HiRO and Differentia Sign MOU for Biopharma Innovation

Harvest Integrated Research Organization (HiRO), a full-service global clinical research organization (CRO), and Differentia Biotech Ltd. ("Differentia"), a pioneer in knowledge-empowered modeling and simulation for drug development, announced a Memorandum of Understanding (MOU) establishing a strategic collaboration …

28 August 2026

Samsung Biologics Secures Funding for Capacity and Global Growth

Samsung Biologics announced a rights offering to raise an expected aggregate amount of KRW 3 trillion to fund investments in the company's three-dimensional, long-term growth strategy across capacity, portfolio, and geographic expansion. The company plans to allocate approximately KRW 2.71 trillion of the offering …

Page 5 of 43

slot gacor